US delays decision on Novartis’ meningitis drug

US authorities have asked Novartis for more information on its meningitis vaccine Menveo, holding up the company`s application to extend the use of the drug to American toddlers and infants, the Swiss drugmaker said on Monday.

US delays decision on Novartis’ meningitis drug

US authorities have asked Novartis for more information on its meningitis vaccine Menveo, holding up the company`s application to extend the use of the drug to American toddlers and infants, the Swiss drugmaker said on Monday.